Receptor-mediated endocytosis of α-galactosidase A in human podocytes in Fabry disease

Keyphrases

• Fabry Disease 100%
• β-Galactosidase (β-Gal) 100%
• Human Podocytes 100%
• Receptor-mediated Endocytosis 100%
• Drug Delivery 66%
• Sortilin 66%
• Glomerular Podocyte 66%
• Treatment Effect 33%
• Insulin-like 33%
• Endocytic Receptors 33%
• Therapeutic Target 33%
• Renal Effects 33%
• Binding Protein 33%
• Surface Expression 33%
• Enzyme Replacement Therapy 33%
• Globotriaosylceramide 33%
• Delivery Capability 33%
• Podocyte Injury 33%
• Intracellular Expression 33%
• Megalin 33%
• Podocyte 33%
• Glomerular Disease 33%
• Intracellular Accumulation 33%
• Mannose-6-phosphate 33%
• Carbohydrate-based Drugs 33%
• Kidney Podocyte 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Fabry Disease 100%
• Galactosidase 100%
• Receptor-Mediated Endocytosis 100%
• Sortilin 66%
• Receptor 33%
• Replacement Therapy 33%
• Enzymes 33%
• Binding Protein 33%
• Carbohydrates 33%
• Insulin 33%
• Megalin 33%
• Glomerulopathy 33%
• Somatomedin B Receptor 33%
• Globotriaosylceramide 33%
• Glomerulonephritis 33%